Synthesis of symmetrical and asymmetrical phenethyl thiourea compounds as nonnucleoside inhibitors of HIV-1 reverse transcriptase

Synthetic Communications

Volumn 35, Issue 15, 2005, Pages 2039-2056

  Venkatachalam, T K ^a,b   Uckun, Faith M ^a,b  

^a PARKER HUGHES INSTITUTE   (United States)

^b Parker Hughes Cancer Center   (United States)

Author keywords

HIV; NNRTI; Thiourea

Indexed keywords

AMINE; IMIDAZOLE DERIVATIVE; N [2 (2 CHLOROPHENETHYL)] N' [2 (2 CHLOROPHENETHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (2 FLUOROPHENTHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (2 METHOXYPHENETHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (2,5 DIMETHOXYPHENETHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (3 CHLOROPHENETHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (3 METHOXYPHENETHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (3,4 DIMETHOXYPHENETHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (4 BROMOPHENETHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (4 CHLOROPHENETHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (4 HYDROXYPHENETHYL)]THIOUREA; N [2 (2 CHLOROPHENETHYL)] N' [2 (4 METHYLPHENETHYL)]THIOUREA; N [2 (3 CHLOROPHENETHYL)] N' [2 (2 FLUOROPHENETHYL)]THIOUREA; N [2 (3 CHLOROPHENETHYL)] N' [2 (2 METHOXYPHENETHYL)]THIOUREA; N [2 (3 CHLOROPHENETHYL)] N' [2 (2,5 DIMETHOXYPHENETHYL)]THIOUREA; N [2 (3 CHLOROPHENETHYL)] N' [2 (3 CHLOROPHENETHYL)]THIOUREA; N [2 (3 CHLOROPHENETHYL)] N' [2 (3 METHOXYPHENETHYL)]THIOUREA; N [2 (3 CHLOROPHENETHYL)] N' [2 (4 BROMOPHENETHYL)]THIOUREA; N [2 (3 CHLOROPHENETHYL)] N' [2 (4 HYDROXYPHENETHYL)]THIOUREA; N [2 (PHENETHYL)] N' [2 (PHENETHYL)]THIOUREA; N,N DIMETHYLFORMAMIDE; PHENETHYL THIOUREA; PHENETHYLAMINE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIOCARBONYLDIIMIDAZOLE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMERIZATION; REACTION ANALYSIS; SOLID;

EID: 23044490717     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1081/SCC-200066677     Document Type: Article

References (18)

1. Cantrell, A. S.; Engelhardt, P.; Hogberg, M.; Jaskunas, S. R.; Johansson, N. G.; Jordan, C. L.; Kangasmetsa, J.; Kinnick, M. D.; Lind, P.; Morin, J. M. Jr.; Muesing, M. A.; Noreen, R.; Oberg, B.; Pranc, P.; Sahlberg, C.; Ternansky, R. J.; Vasileff, R. T.; Vrang, L.; West, S. J.; Zhang, H. Phenethylthiazolylthiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and further structure-activity relationship studies of PETT anlogs. J. Med. Chem. 1996, 39, 4261-4274.
2. Bell, F. W.; Cantrell, A. S.; Hogberg, M.; Jaskunas, S. R.; Johansson, N. G.; Jordan, C. L.; Kinnick, M. D.; Lind, P.; Morin, J. M. Jr.; Noreen, R.; Oberg, B.; Palkowitz, J. A.; Parrish, C. A.; Pranc, P.; Sahlberg, C.; Ternansky, R. T.; Vasileff, R. T.; Vrang, L.; West, S. J.; Zhang, H.; Zhou, X. X. Phenethylthiazolylthiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT anlogs. J. Med. Chem. 1995, 38, 4929-4936.
3. Mao, C.; Vig, R.; Venkatachalam, T. K.; Sudbeck, E. A.; Uckun, F. M. Structure-based design of N-[2-(1-piperidinyl ethyl)]-N′-[2-(5- bromopyridyl)]-thiourea and N-[2-(1-piperazmylethy10]-N′-[2-(5- bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg. Med. Chem. Lett. 1998, 8, 2213-2218.
4. Mao, C.; Sudbeck, E. A.; Venkatachalam, T. K.; Uckun, F. M. Rational design of N-[2-(2,5-dimethoxy phenylethyl)]-N′-[2-(5-bromopyridyl)]- thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus. Bioorg. Med. Chem. Lett. 1999, 9, 1593-1598.
5. Mao, C.; Sudbeck, E. A.; Venkatachalam, T. K.; Uckun, F. M. Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase. Biochem. Pharmacol. 2000, 60, 1251-1265.
6. Uckun, F. M.; Mao, C.; Pendergrass, S.; Maher, D.; Zhu, D.; Tuel-Ahlgren, L.; Venkatachalam, T. K. N-[2-(1-cyclohexenyl)ethyl]-N′-[2-(5- bromopyridyl)]-thiourea and N-[2-(1-cyclohexenyl)ethyl]-N′-[2-(5- chloropyridyl)]-thiourea as potent inhibitors of multi-drug resistant human immunodeficiency virus-1. Bioorg. Med. Chem. Lett. 1999, 9, 2721-2726.
7. Uckun, F. M.; Mao, C.; Pendergrass, S.; Maher, D.; Zhu, D.; Tuel-Ahlgren, L.; Venkatachalam, T. K. N-[2-(4-methylphenyl)ethyl]-N′-[2-(5- bromopyridyl)]-thiourea as a potent inhibitor of NNRTI resistant and multi-drug resistant human immunodeficiency virus. Antiviral. Chem. Chemother. 2000, 11, 135-140.
8. Uckun, F. M.; Pendergrass, S.; Maher, D.; Zhu, D.; Tuel-Ahlgren, L.; Mao, C.; Venkatachalam, T. K. N-[2-(2-Thiophene)ethyl]-N′-[2-(5-bromopyridyl)] -thiourea as a potent inhibitor of NNI-resistant and multi-drug resistant human immunodeficiency virus-1. Bioorg. Med. Chem. Lett. 1999, 9, 3411-3416.
9. Vig, R.; Mao, C.; Venkatachalam, T. K.; Tuel-Ahlgren, L.; Sudbeck, E. A.; Uckun, F. M. 5-Alkyl-2-[(methylthiomethyl)thio]-6-[(benzyl)-pyrimidin-4-(1H)- ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series. Bioorg. Med. Chem. Lett. 1998, 8, 1461-1466.
10. Venkatachalam, T. K.; Uckun, F. M. Synthesis of β-fluorophenethyl halopyridyl thiourea compounds as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Synth. Commun. 2004, 34, 2462-2472.
11. Venkatachalam, T. K.; Uckun, F. M. Regiospecific synthesis of 5-halo-substituted thiophene pyridyl thiourea compounds as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Synth. Commun. 2004, 34, 1-11.
12. Mallikarjun, P.; Venkatachalam, T. K.; Uckun, F. M. Introduction of carbohydrate moiety into the structure of thiourea compounds targeting HIV-1 reverse transcriptase. Synth. Commun. 2003, 33, 1185-1193.
13. Venkatachalam, T. K.; Mao, C.; Uckun, F. M. Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: Viral potency of chiral PETT derivatives. Biochem. Pharmacol. 2004, 67, 1933-1946.
14. Venkatachalam, T. K.; Mao, C.; Uckun, F. M. Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds. Bioorg. Med. Chem. 2004, 12, 4275-4284.
15. Venkatachalam, T. K.; Mao, C.; Uckun, F. M. Stereochemistry as a major determinant of the anti-HIV activity of chiral naphthyl thiourea compounds. Antivir. Chem. Chemother. 2001, 12, 213-221.
16. Venkatachalam, T. K.; Sudbeck, E. A.; Mao, C.; Uckun, F. M. Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg. Med. Chem. Lett. 2000, 10, 2071-2074.
17. Wallingford, V. H.; Krueger, P. A. Organic Synthesis; Wiley: New York, 1957; Vol. 2, pp. 349-351.
18. Fieser, L. F.; Fieser, M. Reagents for Organic Synthesis; Wiley: New York, 1967; Vol. 1, pp. 1151-1152.